Adagio Medical Holdings, Inc Common Stock

Day range

$0.09 – $0.11

Open

$0.10

Prev close

$0.10

Volume

618.02K

Market cap

$2.82M

Shares out

27.44M

• Warrant or conversionOct 1, 2026

  Following the Alternate Conversion Election, between September 25, 2026 and October 1, 2026, a Holder exercised its right to convert $776,111 aggregate principal amount (together with accrued and unpaid interest thereon, if any) of the Notes (the “Alternate Conversion”), resulting in the issuance of 4,978,869 shares of Common Stock, calculated using Alternate Conversion Prices ranging from $0.1265 to $0.1618 per share.

• Workforce reductionSep 23, 2026

  As part of the plan, the Company will reduce its workforce by 25 of 43 full-time employees, effective September 23, 2026. The Company estimates that it will incur approximately $1.3 million of cash expenditures, consisting primarily of one-time severance payments, benefits and other related costs.

• Listing deficiency noticeAug 14, 2026

  On August 13, 2026, Adagio Medical Holdings, Inc. received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it is not in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders' equity of at least $2,500,000. The Company's Quarterly Report on Form 10-Q for the period ended June 30, 2026, reported stockholders' equity of $(415,000).

• Investor presentationAug 13, 2026

  On August 13, 2026, Adagio Medical Holdings, Inc. (the "Company") made available an updated corporate presentation for use in meetings with investors, analysts and others. The presentation is available through the Company's website and a copy is attached as Exhibit 99.1 to this Current Report on Form 8-K.

• Annual meeting resultsJun 16, 2026

  On June 16, 2026, Adagio Medical Holdings, Inc. held its 2026 Annual Meeting of Stockholders. The stockholders considered two proposals... Both nominees were elected. Ratification of the appointment of WithumSmith+Brown, PC as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Days to cover

1.0

Short interest

1.29M

Avg volume

4.54M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Adagio Medical Heart Ablation System Shows 84% Freedom From Shock
  positiveBenzinga· Apr 27, 2026
• Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment
  positiveGlobeNewswire Inc.· Sep 3, 2025